logo
Share SHARE
FONT-SIZE Plus   Neg

Forest Labs, Pierre Fabre Report Results In Phase III Trial Of Levomilnacipran

Forest Laboratories, Inc. (FRX) and Pierre Fabre Medicament announced positive top-line results in a Phase III clinical trial of levomilnacipran, an investigational agent for the treatment of adults with major depressive disorder, or MDD.

Treatment with levomilnacipran significantly reduced depression symptoms in patients with MDD versus placebo, as early as week one and at each subsequent visit as measured by the Montgomery-Asberg Depression Rating Scale-Clinician Rated. Levomilnacipran was generally well-tolerated in this study. The premature discontinuation rates were 25 percent for levomilnacipran and 21 percent for placebo. The most common adverse events observed in the levomilnacipran group were nausea, dizziness and constipation.

Results from an additional placebo-controlled Phase III fixed-dose study are expected in Spring 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
German auto giant BMW Group (BMW.L, BAMXF.PK, BAMXY.PK) reported Tuesday higher net profit in its first quarter, while EBIT, a key earnings metric, declined on weak automotive revenues. Sales volumes, however, increased from last year. Further, the company confirmed its fiscal 2016 forecast, expecting slight increases. BMW shares were losing around 3 percent in the morning trading in Germany. Shares of UBS AG were losing around 5 percent in the morning trading after the Swiss financial services giant reported Tuesday sharply lower profit in its first quarter amid lower net fee and commission as well as trading income. Net interest income, however, improved from last year. Looking ahead, the company said that the ongoing underlying macroeconomic challenges and geopolitical risks ... Asia-focused lender HSBC Holdings Plc reported Tuesday a decline in the first-quarter profit, on weak revenues and net interest income. The results reflected weak performance in all segments and business regions, except Middle East and North Africa as well as CMB.
comments powered by Disqus
Follow RTT